Bionano Genomics(us:BNGO)

2.79

-3.79%

Updated on 2025-03-31

Open:2.93
Close:2.79
High:2.93
Low:2.68
Prev Close:2.90
Volume:50909.00
Turnover:143144.38
Turnover Ratio:1.86%
Shares:2.73M
MarketCap:7.62M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-307766081739.34%171133
2024-03-318550565208.79%171339
2023-12-3177617713713.50%251522
2023-09-30124521758514.76%51992
2023-06-3016052562541.58%322082
2023-03-311578147457926.60%94564
2022-12-311748251245227.76%275756
2022-09-301737990744826.91%183572
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Vanguard Group Inc18947613.29%11160.06%
2024-03-31Gsa Capital Partners Llp5497890.96%462887532.65%
2024-03-31Geode Capital Management, Llc4013800.70%245786.52%
2024-03-31Blackrock Inc.3853500.67%-120010-23.75%
2024-03-31Citadel Advisors Llc2402150.42%3799718.79%
2024-03-31Jane Street Group, Llc1578230.27%89179129.91%
2024-03-31Cetera Investment Advisers1476510.26%147651
2024-03-31Cetera Advisors Llc1468060.26%146806
2024-03-31State Street Corp1139880.20%0
2024-03-31Northern Trust Corp1071550.19%-3114-2.82%

About

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Address:9540 Towne Centre Drive,Suite 100

Market Movers